NASDAQ:MIRM   Mirum Pharmaceuticals, Inc.
*This is not financial advice, so trade at your own risks*

*My team digs deep and finds stocks that are expected to perform well based off multiple confluences*

*Experienced traders understand the uphill battle in timing the market, so instead my team focuses mainly on risk management*
Mirum Pharmaceuticals:

My team has been reviewing Mirum Pharmaceuticals for close to two months, and despite its poor performance in the past month it remains one of top picks for the month of June.

Mirm is to present data for their assets which target rare liver diseases on June 3rd 2021. Its recent price rejection at $15.85 increases our confidence in this play. There have been jumps from this zone up to $20-26, so we expect a similar pattern to repeat. Next week's data results simply have to be adequate enough to regain investor attention. My team is especially confident in the risk-to-reward ratio of this trade.

We entered today @$16.30. Short term take profit @$20.00 Long Term take profit @$30.00

Stop Loss @$14.90

If you want to see more, please like and follow us @SimplyShowMeTheMoney
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.